ASCO 2024: Breakthroughs in Breast Cancer

The American Society of Clinical Oncology (ASCO) annual meeting is one of the largest gatherings of oncology professionals globally, and this year’s event showcased numerous…

What’s Next in the Great GLP-1 Race?

 Roche Holding (RHHBY) joined the race to commercialize its own GLP-1 (glucagon-like peptide-1) receptor agonist drug this week, announcing that its dual-agonist asset, CT-388, had…

A Changing Landscape: AI In Biotechnology

The use of artificial intelligence (AI) in biotechnology offers companies a compelling opportunity to accelerate and optimize drug development, a process that is time consuming,…

Advancing Vaccines for Cancer

Cancer was responsible for nearly 10 million deaths in 2020. Treatments for cancer, which represents a group of complex and diverse diseases, have been in…